All - 127,417 Studies Found
| Completed |
: Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease : Cushing's Disease : 2014-06-17 : Drug: LCI699 |
| Active, not recruiting |
: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease : Cushing's Disease : 2013-06-10 : Drug: Pasireotide with or without cabergoline The trial consists of Pasireotide-untreated patients will |
| Completed |
: Cushing's Disease Complications : Cushing's Disease : 2015-07-20 : Other: Exams and questionnaires Blood sample 24hrs urinary cortisol and salivary cortisol, urinary labst |
| Completed |
: Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease : Cushing Disease : 2005-09-13 : Drug: Pasireotide |
| Completed |
: Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease : Cushing's Disease : 2011-06-14 :
|
| Completed |
: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease : Cushings Disease : 2014-09-26 : Drug: SOM230 |
| Completed |
: Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease : Cushing's Disease : 2007-02-09 : Drug: Pasireotide |
| Active, not recruiting |
: Safety and Efficacy of LCI699 in Cushing's Disease Patients. : Cushing's Disease : 2011-04-06 : Drug: LCI699 |
| Completed |
: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. : Cushing's Disease : 2012-04-12 : Drug: Pasireotide sub-cutaneous formulation Pasireotide will be administered twice a day until pasireoti |
| Active, not recruiting |
: Cushing´s Disease Epidemiology in Sweden : Cushing Disease : 2014-12-05 |